Model
Edge
Regeneron Pharmaceuticals, Inc.
REGN
Filing Type
144
Filing Date
2/8/2026
Updated
2/9/26, 3:02 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities